Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for prevention of depression after first-episode psychosis
ISRCTN12682719Phase 4Completed
- Sponsor
- University of Birmingham
- Start
- Feb 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoint: New cases of depression over 6 months at 12 months. Started Feb 2021; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN12682719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12682719.